Agfa HealthCare - Third Quarter 2010

Agfa HealthCareConfirming the positive trend of the previous quarter, Agfa HealthCare's revenue increased 5.5 percent (excluding currency effects: -0.6 percent) compared to the third quarter of 2009. The growth was mainly contributable to the strong performances of both Imaging IT and Enterprise IT.

IT revenue continued its positive trend in the Northern European markets, whereas business in the Southern European countries still suffered from the unstable economic climate. In the emerging countries, Imaging IT continued to perform strongly.

The business group's gross profit margin improved from 38.9 percent in the third quarter of 2009 to 39.7 percent. The improved service efficiency in IT was partially offset by unfavourable raw material conditions. Agfa HealthCare's recurring EBITDA amounted to 39.7 million Euro (or 13.7 percent of revenue). Recurring EBIT improved to 27.7 million Euro, or 9.6 percent of revenue, versus 8.3 percent in the third quarter of 2009.

In the field of healthcare IT (including Imaging Informatics and Enterprise IT), Agfa HealthCare signed over 150 agreements with new customers during the first three quarters of the year. These customers include a wide range of healthcare providers, from large multi-site facilities and regional care providers, to medium sized facilities and imaging centers, spanning a global geographical coverage. Also in IT, Agfa HealthCare announced technology innovations in the fields of Radiology with its IMPAX Data Center solutions, in Cardiology with its IMPAX Cardiology & Heartstation solutions and in the field of Nursing with its ORBIS Care solutions.

In the field of Imaging, Agfa HealthCare announced that it further expanded the geographic availability of the new members of its DX-D offering of direct radiography solutions. Both the DX-D 300 and the DX-D 500n system - now also available in the USA - support a wide range of radiographic exams, while ensuring optimal radiation dose and superb image quality.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,755 million euro in 2009.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2009 were 1,178 million euro. For more information on Agfa HealthCare, please visit www.agfahealthcare.com.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...